Search Results - "Kitadai R"

Rechallenge of immune checkpoint inhibitors in advanced non‐small cell lung cancer.

Authors: Lin, Gen Wang, Zhijie Chu, Qian et al.

Source: Thoracic Cancer. Feb2024, Vol. 15 Issue 5, p419-426. 8p.

Germline variants of the POLH and RAD51 genes are candidate variants associated with risk of hormone receptor-negative young-onset breast cancer.

Authors: Yazaki S Kitadai R Momozawa Y et al.

Corporate Authors: Yazaki S Kitadai R Momozawa Y et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2025 Nov 28; Vol. 11 (1), pp. 133. Date of Electronic Publication: 2025 Nov 28.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Translational development of an SGLT2-targeted near-infrared contrast agent for intraoperative imaging of early-stage lung cancer.

Authors: Ortmeyer, Katherine A. McGovern, Kelly A. Tidwell, Jerica et al.

Source: EJNMMI Research. 5/4/2026, Vol. 16 Issue 1, p1-10. 10p.

Clinical implications of discordance in HER2 reassessment from HercepTest to 4B5 in metastatic breast cancer.

Authors: Yamaguchi Y Hoshino M Shimoi T et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2026 Jun 22; Vol. 217 (3). Date of Electronic Publication: 2026 Jun 22.

Publication Type: Journal Article

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Frequency of expression and prognostic implications of emerging molecular targets in pulmonary squamous cell carcinoma.

Authors: Pandey, Rahul Kumar Shukla, Saumya Husain, Nuzhat et al.

Source: Indian Journal of Pathology & Microbiology. Jan-Mar2026, Vol. 69 Issue 1, p16-22. 7p.

Use of Next-Generation Sequencing for Highly Endocrine-Sensitive Metastatic Breast Cancer to Inform Late-Phase Treatments with Sustained Response: A Case Report.

Authors: Bayat, Leyla McCabe, Margaret Cherneykin, Sergey et al.

Source: Case Reports in Oncology. Apr2026, Vol. 19 Issue 1, p777-784. 8p. 1 Illustration, 2 Charts.

Real-World Predictors of Survival in CDK4/6 Inhibitor-Treated Metastatic Breast Cancer: The Significance of ER Expression Level and Treatment Naivety.

Authors: Bülbül, Büşra Ucun, Bekir Cangür, Can et al.

Source: Current Oncology. Dec2025, Vol. 32 Issue 12, p709. 13p.

Baseline risk variability by eligibility criteria in Cohort 1 of the monarchE trial for high-risk HR-positive, HER2-negative breast cancer.

Authors: Hoshino M Shimoi T Yamanaka T et al.

Source: Breast cancer (Tokyo, Japan) [Breast Cancer] 2025 Nov; Vol. 32 (6), pp. 1269-1276. Date of Electronic Publication: 2025 Jul 28.

Publication Type: Journal Article

Journal Info: Publisher: Maruzen Co Country of Publication: Japan NLM ID: 100888201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-4233 (Electronic) Linking ISSN: 13406868 NLM ISO Abbreviation: Breast Cancer Subsets: MEDLINE

A Real-World, Single-Center, Observational Retrospective Experience of Durvalumab Treatment After Concomitant Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer.

Authors: Wojskowicz, Agnieszka Skalij, Piotr Hempel, Dominika et al.

Source: Cancers. Mar2026, Vol. 18 Issue 6, p1044. 19p.

Photocatalytic Asymmetric C‐C Coupling for CO2 Reduction on Cu‐Zn Bimetallic Catalysts with Dipole‐Limiting Effects.

Authors: Ma, Peidong Yu, Ying Wen, Fan et al.

Source: Advanced Science. 2/23/2026, Vol. 13 Issue 11, p1-12. 12p.

Hypoxia-Inducible Factor-1α, a Novel Molecular Target for a 2-Aminopyrrole Derivative: Biological and Molecular Modeling Study.

Authors: Zykova, Svetlana S. Gessel, Tatyana Galembikova, Aigul et al.

Source: Cancers. Jan2026, Vol. 18 Issue 1, p115. 24p.

Baseline tumor burden predicts the efficacy of first-line chemoimmunotherapy in patients with advanced non-small cell lung cancer: results from 2 phase 3 randomized placebo-controlled trials.

Authors: He, Xinyi Shi, Mengting Zhang, Lin et al.

Source: BMC Cancer. 8/27/2025, Vol. 25 Issue 1, p1-10. 10p.

Immunotherapy rechallenge of patients with advanced NSCLC progression after sequential treatment with third-generation EGFR-TKI and immunotherapy.

Authors: Hu, Shuyi Wu, Zipeng Dai, Yingying et al.

Source: Cancer Biology & Medicine. Dec2025, Vol. 22 Issue 12, p1544-1552. 9p.

Therapy with Immune Checkpoint Inhibitors for Solid Tumors in Patients with Preexisting Systemic Autoimmune Diseases.

Authors: Campos Ramírez, Sara Elena Gómez Mugarza, Pablo Gomila Pons, Paula et al.

Source: Journal of Clinical Medicine. Nov2025, Vol. 14 Issue 21, p7765. 12p.

Docetaxel and Ramucirumab as Subsequent Treatment After First-Line Immunotherapy-Based Treatment for Metastatic Non-Small-Cell Lung Cancer: A Retrospective Study and Literature Review.

Authors: Loizidis, Sotiris Vogazianos, Paris Kordatou, Zoe et al.

Source: Current Oncology. Nov2025, Vol. 32 Issue 11, p612. 16p.

Comparison of the Efficacy of First-Line Pemetrexed-Platinum and Gemcitabine-Platinum Regimens in Malignant Peritoneal Mesothelioma.

Authors: Bayram, Doğan Efil, Safa Can Türk, Serap et al.

Source: Clinical Medicine Insights: Oncology. 10/17/2025, Vol. 19, p1-10. 10p.

Locally advanced non-small cell lung cancer with negative or low programmed death ligand 1 expression: a prognostic factor analysis of real-world data after the PACIFIC trial.

Authors: Kashihara, Tairo Nakayama, Yuko Okuma, Kae et al.

Source: Radiation Oncology. 10/16/2025, Vol. 20 Issue 1, p1-12. 12p.

Folate Receptor Alpha in Advanced Epithelial Ovarian Cancer: Diagnostic Role and Therapeutic Implications of a Clinically Validated Biomarker.

Authors: Zannoni, Gian Franco Santoro, Angela d'Amati, Antonio et al.

Source: International Journal of Molecular Sciences. Jun2025, Vol. 26 Issue 11, p5222. 12p.

Tissue-agnostic target profiles and treatment efficacy in cancer patients: Insights from the C-CAT clinicogenomic repository.

Authors: Kitadai R Okuma Y Shibata T et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 May 02; Vol. 220, pp. 115380. Date of Electronic Publication: 2025 Mar 24.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

The Role of Mesothelin in Gynecological Tumors and Its Significance in Targeted Therapies—A Review.

Authors: Kawecka, Weronika Wilczyński, Jacek R. Tyczyńska, Magdalena et al.

Source: Cancers. Jun2026, Vol. 18 Issue 11, p1692. 17p.